Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumab.

ABSTRACT:

Background

The effort-independent tidal breathing test used by oscillometry presents a viable alternative for following up patients whose condition is stable while they are receiving biologic therapy.

Objective

We aimed to determine intrasession and intersession repeatability values for airwave oscillometry (AOS) and spirometry in patients who were already taking benralizumab.

Methods

In all, 21 patients with severe eosinophilic asthma attended the Scottish Centre for Respiratory Research as part of a clinical trial (EudraCT identification number 2019-003763-22). Paired AOS and spirometry values were obtained at 3 separate visits (baseline and days 28 and 56) with no change in asthma therapy.

Results

Intrasession agreement between repeated measurements for AOS

SUBMITTER: Chan R 

PROVIDER: S-EPMC10509948 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature